at-101
Showing 1 - 10 of 10
Laryngeal Cancer Trial in Ann Arbor (AT-101, Docetaxel, Cisplatin)
Completed
- Laryngeal Cancer
- AT-101
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 17, 2021
Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Ann Arbor, Detroit (AT-101, Docetaxel)
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- AT-101
- Docetaxel
-
Ann Arbor, Michigan
- +1 more
Mar 3, 2016
Adenocarcinoma of the Prostate, Stage IV Prostate Cancer Trial in United States (AT-101, Bicalutamide, LHRH agent)
Completed
- Adenocarcinoma of the Prostate
- Stage IV Prostate Cancer
- AT-101
- +2 more
-
Chicago, Illinois
- +3 more
Dec 17, 2014
Locally Advanced Esophageal or GE Junction Cancer Trial in Houston (AT-101)
Terminated
- Locally Advanced Esophageal or GE Junction Cancer
- AT-101
-
Houston, TexasMD Anderson Cancer Center
Jan 3, 2013
Prostate Cancer Trial in United States (AT-101)
Completed
- Prostate Cancer
- AT-101
-
Hot Springs, Arkansas
- +12 more
Jun 27, 2011
Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in United States (AT-101)
Completed
- Follicular Lymphoma
- +4 more
- AT-101
-
Birmingham, Alabama
- +10 more
Jun 24, 2011
Hormone Refractory Prostate Cancer Trial in United States (AT-101)
Completed
- Hormone Refractory Prostate Cancer
- AT-101
-
Greenbrae, California
- +3 more
Aug 20, 2010
Chronic Lymphocytic Leukemia Trial in San Diego (AT-101)
Completed
- Chronic Lymphocytic Leukemia
- AT-101
-
San Diego, CaliforniaUCSD Moores Cancer Center
Aug 12, 2010